Please provide your email address to receive an email when new articles are posted on . Between baseline and week 6, the number of coughs per hour significantly fell among those receiving extended ...
BARCELONA -- An investigational opioid agonist/antagonist reduced chronic cough frequency in patients with idiopathic pulmonary fibrosis (IPF), interim findings from a small randomized study showed.
Aldeyra Therapeutics Inc ALDX announced top-line results from the Phase 2 clinical trial of ADX‑629, an investigational new drug administered orally to patients with chronic cough. The company plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results